MedTrace Logo

Gastric Cancer Metastasized to the Central Nervous System (CNS)

NCT01456455 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2016-10-25

No results posted yet for this study

Summary

Descriptive registry to investigate frequency of HER-2 positive gastric cancer involving CNS.

Exploration of additional prognostic factors for brain involvement from gastric cancer.

Conditions

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • 01 Studienregister MasterAdmins · UniversitaetsSpital Zuerich

  • Silvia Hofer, MD · University Hospital Zurich, Division of Oncology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2020-03-31
Completion
2020-08-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01456455 on ClinicalTrials.gov